In 2025, Sichuan Kelun Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 502,670.77a | 505,678.93a | 454,078.15a | |
Total Waste Recovered | 14,198.59a | 8,453.87a | 7,554.16a | |
Total Hazardous Waste Generated | 252,201.12a | 251,112.33a | 217,767.81a | |
Non-Hazardous Waste Disposed | 236,940.84a | 247,217.62a | 229,034.82a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Sichuan Kelun Pharmaceutical generated a total of 502,671metric tonnes of waste.a
Of this amount, 2.82% of Sichuan Kelun Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 100.69% was disposed of through landfilling, incineration, or combustion.a
In 2025, Sichuan Kelun Pharmaceutical reported a total waste generation of 502,671 metric tonnes, of which 2.82% was recovered through recycling, reuse, or composting.This low recovery rate highlights limited waste diversion and suggests that Sichuan Kelun Pharmaceutical may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.a
Since 2023, Sichuan Kelun Pharmaceutical's total waste generation increased by 10.7%, but remained relatively stable in 2025, suggesting that past growth in waste production may have recently plateaued.a
Over the same period, Sichuan Kelun Pharmaceutical's waste recovery rate increased by 69.79%, including a 68.96% rise in 2025, indicating growing emphasis on circularity and improved operational practices for diverting waste from disposal.a
Overall, Sichuan Kelun Pharmaceutical continues to maintain a high level of waste generation, but steady recovery improvements point to more responsible waste handling and an ongoing investment in circularity.
In 2025, Sichuan Kelun Pharmaceutical generated a total of 502,671 metric tonnes of waste.a
Of this amount, 50.17% of Sichuan Kelun Pharmaceutical's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.49.83% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a
Since 2023, Sichuan Kelun Pharmaceutical's total waste generation rose by 10.7%, yet remained stable in 2025, suggesting recent efforts may have paused further escalation, though historical accumulation remains a concern.a
Over the same period, the share of hazardous waste in Sichuan Kelun Pharmaceutical's total output increased by 4.62%, including a further 1.03% rise in 2025, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.a
Overall, Sichuan Kelun Pharmaceutical's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.a
In 2025, Sichuan Kelun Pharmaceutical reported that 252,201 metric tonnes of its total waste output were classified as hazardous. This represents 50.17% of its overall waste generation.a
The company treated this hazardous waste using a combination of methods.Only 0.26% of hazardous waste was recovered, meaning the vast majority was treated through disposal methods such as landfilling or incineration. This raises concerns about the environmental and health risks associated with Sichuan Kelun Pharmaceutical’s current hazardous waste practices.a